In the context of MI, inhibition of EZH2-induced cardiac recruitment and enhanced activity of non-classical monocytes accelerates the resolution of inflammation and reduces infarct scar expansion, thereby contributing to decreased cardiac remodeling and dysfunction after MI (Rondeaux et al., 2023). Here, EZH2 is linked to myocardial infarction.